Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Shenzhen Neptunus Interlong Bio-technique Company Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1382
First IPO Date
September 12, 2005
Key Executives
| Name | Title | Pay | Year Born |
| Feng Zhang | Executive Chairman & Compliance Officer | 115,904 | 1972 |
| Jian Bo Huang | Vice GM, Financial Controller, Joint Company Secretary & Executive Director | 735,991 | 1976 |
| Xiao Guang Zhang | Executive Director | 1.1M | 1964 |
| Yang Cao | Human Resources Director | 0 | 1991 |
| Wai Sum Fung | Joint Company Secretary | 0 | 1983 |
AD
Description
Based in Shenzhen, People's Republic of China, Shenzhen Neptunus Interlong Bio-technique Company Limited and its subsidiaries are primarily engaged in the research, development, production, and sale of pharmaceuticals. The company also handles the procurement, distribution, and marketing of medicines and health food items, while undertaking research and development in biological technology. Its manufacturing operations encompass herbal medicines, generic drugs, and medical devices. This entity operates as a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.
AD
